The Big Question on the Minds of Every 340B Stakeholder By Ted Slafsky As we pass the third anniversary of the pharmaceutical industry’s surprise decision to significantly scale back access to 340B pricing in the contract pharmacy setting, the key question is:  Why is it taking so long to come up with a resolution?  One […]

The Growing Inevitability of New 340B Reporting Requirements By Ted Slafsky Just before the end of most state legislative sessions for 2023, two states enacted the first ever 340B-specific reporting requirements for covered entities. As my colleague Will Newton reported in 340B Report, Minnesota was the first to enact a reporting law. It is a […]

Lessons from Two State Legislatures and What They Mean for 340B Stakeholders By Ted Slafsky As many 2023 state legislative sessions come to an end, it is a good time to take a closer look at two states—one in the South and one in the Northeast—to see how they are tackling some of the most […]

Could We Have a Breakthrough in the Contract Pharmacy Battle? By Ted Slafsky As we reach the third-year mark since pharmaceutical manufacturers began to restrict access to 340B pricing in the contract pharmacy setting, we recently experienced a watershed moment that I believe will lead to an end of the standoff between the government and […]

A Cheat Sheet of the Growing List of 340B Groups By Ted Slafsky With the recent launch of 340B Truth and with several other advocacy/educational groups using 340B in their names, it is a good time to provide a tutorial on the different groups and their goals.  The list below is not exhaustive but reflects […]

The emergence of success is hidden in years of hard work, reflection and commitment. Welcome! We’re glad you stopped by! As you join your colleagues from across the country this week to learn and network, we’d like to share a few things… Read the latest article from our guest contributor, Ted Slafsky: Reflecting on the […]

Reflecting on the NACHC-PhRMA 340B Alliance By Ted Slafsky Many of us in the 340B community are still trying to digest the news that the National Association of Community Health Centers has formed an alliance with PhRMA and will be advocating for major reforms to the 340B program. The creation of the Alliance to Save […]

Could We Have the Makings of a Grand Bargain on 340B? By: Ted Slafsky For the past three decades, hospitals and federal grantees have been more successful than pharmaceutical companies when it comes to policy changes to the 340B drug discount program.  Despite the drug industry’s deeper pockets, 340B covered entities have been able to […]

Three 340B Observations for 2023 By: Ted Slafsky I am very excited to be writing my inaugural column for Verity Solutions’ blog.  I have a long-time friendship with Verity’s CEO George Puckett that spans close to three decades and have always admired and counted on the Verity team for their expertise on 340B matters.  I […]

It begins with our team. Every Verity team member feels a deep sense of purpose to their work and an immeasurable commitment to helping our customers achieve their goals with the 340B program. We are inspired by people’s passion for their work and the direct impact of the 340B Program as part of the healthcare […]